Lymphoma

• EMA approval · 2025-10-27
  EMA Authorised: Elzonris (tagraxofusp) — Stemline Therapeutics B.V.

  The EMA authorised Elzonris (tagraxofusp) for a lymphoma indication and designated it as an orphan medicine (decision date 17 September 2025…

• EMA approval · 2024-07-31
  EMA Authorised: Mozobil (Plerixafor) — Sanofi B.V.

  The EMA authorised Mozobil (plerixafor) from Sanofi B.V. for multiple myeloma and lymphoma indications, including use in hematopoietic stem …

• FDA approval · 2018-07-27
  FDA Approved: LEUCOVORIN CALCIUM — Original Application (Fresenius Kabi USA, LLC)

  FDA approved a generic Leucovorin Calcium under ANDA 207226 for Fresenius Kabi USA, LLC.